This guidance has been adapted for Canadian use from the WHO document entitled "Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected – Interim guidance - 13 March 2020". This guidance is informed by currently available scientific evidence and expert opinion, and is subject to change as new information becomes available.
- Publisher - Current Organization Name: Public Health Agency of Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Clinical management of patients with moderate to severe COVID-19 - Interim guidancePDFEnglish publication PDF
-
Clinical management of patients with moderate to severe COVID-19 - Interim guidancePDFFrench publication PDF
Similar records